Filtering

P117 Biomarkers of extracellular matrix remodelling are associated with intestinal fibrosis assessed by magnetic resonance enterography and accumulated intestinal damage (Lémann index): the IBSEN study

ECCO'20 Vienna

Year: 2020
Authors:

J. Mortensen1, A.K. Lunder2, T. Manon-Jensen1, M.A. Karsdal1, M.J. Nielsen1, D.J. Leeming1, J.R. Hov3, A. Negård2,4, J. Jahnsen4,5, B. Moum4,6, M. Vesterhus7,8,9,10, M.L. Høivik11, V.A. Kristensen11

1Nordic Bioscience A/S, Department of Biomarkers and Research, Herlev, Denmark, 2Akershus University Hospital, Department of Radiology, Lørenskog, Norway, 3University of Oslo, Department of Transplantation Medicine, Oslo, Norway, 4University of Oslo, Institute of Clinical Medicine, Oslo, Norway, 5Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway, 6University Hospital Oslo, Department of Gastroenterology, Oslo, Norway, 7Oslo University Hospital Rikshospitalet, Norwegian PSC Research Center, Oslo, Norway, 8Haraldsplass Deaconess Hospital, Department of Medicine, Bergen, Norway, 9University of Bergen, Department of Clinical Science, Bergen, Norway, 10Oslo University Hospital Rikshospitalet, Department of Transplantation Medicine, Oslo, Norway, 11Oslo University Hospital, Department of Gastroenterology, Oslo, Norway

P118 A comprehensive evaluation of mucosal redness in patients with ulcerative colitis by linked colour imaging

ECCO'20 Vienna

Year: 2020
Authors:

K. Uchiyama, M. Kubota, Y. Azuma, R. Yasuda, T. Shun, T. Takagi, Y. Naito, I. Yoshito

Kyoto Prefectural University Of Medicine, Department of Molecuar Gastroenterology and Hepatology, Kyoto, Japan

P119 Brain function and fatigue in patients with inflammatory bowel disease

ECCO'20 Vienna

Year: 2020
Authors:

A. Thomann1, M. Schmitgen2, D. Kmuche3, M. Griebe3, M. Ebert1, R.C. Wolf2, W. Reindl1

1Medical Faculty Mannheim, Heidelberg University, Department of Medicine II, Mannheim, Germany, 2Heidelberg University Hospital, Department of General Psychiatry, Heidelberg, Germany, 3Medical Faculty Mannheim, Heidelberg University, Department of Neurology, Mannheim, Germany

P120 Prevalence of endoscopic improvement and endoscopic remission according to patient reported outcomes in ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

P. Dulai1, S. Singh1, V. Jairath2, C. Ma3, N. Narula4, N. Vande Casteele1, L. Peyrin-Biroulet5, S. Vermeire6, G. D’Haens7, B. Feagan2, W. Sandborn1

1University of California San Diego, Gastroenterology, San Diego, USA, 2University of Western Ontario, Gastroenterology, London, Ontario, Canada, 3University of Calgary, Gastroenterology, Calgary, Alberta, Canada, 4McMaster University, Gastroenterology, Hamilton, Ontario, Canada, 5Nancy University Hospital, Gastroenterology, Nancy, France, 6University Hospitals Leuven, Gastroenterology, Leuven, Belgium, 7Academic Medical Center, Gastroenterology, Antilles, Amsterdam, The Netherlands

P121 Real-world use of the IBD disk tool in unselected cohorts of outpatients

ECCO'20 Vienna

Year: 2020
Authors:

N. Sharma1, E. Savelkoul2, B. Disney3, A. Shah4, S. De Silva5, S. Pattni6, M. Iacucci7, R. Cooney8, S. Ghosh9

1Institute of Immunology and Immunotherapy, University of Birmingham, Gastroenterology, Birmingham, UK, 2Radboudumc, Gastroenterology, Nijmegen, The Netherlands, 3University Hospitals Coventry and Warwickshire, Gastroenterology, Coventry, UK, 4The Royal Wolverhampton NHS Trust, Gastroenterology, Wolverhampton, UK, 5The Dudley Group NHS Foundation Trust, Gastroenterology, Dudley, UK, 6University Hospitals Of Leicester NHS Trust, Gastroenterology, Leicester, UK, 7Institute of Translational Medicine- Institute of Immunology and Immunotherapy, NIHR Biomedical Research Centre- University of Birmiingham, Birmingham, UK, 8Queen Elizabeth Hospital Birmingham, Gastroenterology, Birmingham, UK, 9Institute of Translational Medicine, Institute of Immunology and Immunotherapy, NIHR Birmingham Biomedical Research Centre, Birmingham, UK

P122 High correlation between faecal calprotectin and a Novel Integral Index for evaluating disease activity in ulcerative colitis patients

ECCO'20 Vienna

Year: 2020
Authors:

J.K. Yamamoto-Furusho MD, PhD1, E.A. Mendieta-Escalante2

1National Institute of Medical Science and Nutrition Salvador Zubiran, Department of Gastroenterology, Mexico City, Mexico, 2IBD Clinic, Department of Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion, Gastroenterology, Mexico, Mexico

P123 Sarcopenia is a predictor for severe disease course in paediatric inflammatory bowel disease

ECCO'20 Vienna

Year: 2020
Authors:

L. Atlan1,2, L.T. Pratt1,2, S. Cohen2,3, S. Shiran1,2, A. Yerushalmy-feler2,3

1Tel Aviv Sourasky Medical Center, Department of Radiology, Tel Aviv, Israel, 2Tel Aviv University, The Sackler Faculty of Medicine, Tel Aviv, Israel, 3Tel Aviv Sourasky Medical Center, Department of Pediatric Gastroenterology, Tel Aviv, Israel

P124 Clock gene expression levels can differentially distinguish between ulcerative colitis and Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

Y. Weintraub1, S. Cohen1, N. Chapnik2, A. Yerushalmy-Feler1, A. Ben-Tov1, I. Dotan3, R. Tauman4, O. Froy2

1Sourasky Medical Center, Tel Aviv-Israel, Pediatric Gastroenterology, Tel Aviv, Israel, 2The Hebrew University, Institute of Biochemistry, Food Science and Nutrition, the Robert H Smith Faculty of Agriculture- Food and Environment, Rehovot, Israel, 3Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel, 4Sourasky Medical Center, Tel Aviv-Israel, Sleep Disorders Center, Tel Aviv, Israel

P125 Histological activity as a predictor of clinical outcome in ulcerative colitis: a 1-year prospective study

ECCO'20 Vienna

Year: 2020
Authors:

B. Neri1, S. Romeo1, A. Ruffa1, E. Calabrese1, G. Sena1, E. Grasso1, F. Zorzi1, G. Palmieri2, S. Soldati3, L. Biancone1

1University ‘Tor Vergata’ of Rome, Systems Medicine, Roma, Italy, 2University ‘Tor Vergata’ of Rome, Pathology Unit, Roma, Italy, 3Lazio Regional Health Service, Department of Epidemiology, Rome, Italy

P126 The Urgency Numeric Rating Scale (NRS): a novel patient-reported outcome measure to assess bowel urgency in adult patients with ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

M.C. Dubinsky1, A. Naegeli DrPH, MPH2, Y. Dong3, T. Lissoos4, V. Arora3, P. Irving5

1Icahn School of Medicine- Mount Sinai Hospital, Pediatric GI and Nutrition, New York City, USA, 2Eli Lilly and Company, Global Patient Outcomes and Real World Evidence, Indianapolis, USA, 3Eli Lilly and Company, Global Statistical Sciences, Indianapolis, USA, 4Eli Lilly and Company, Gastroenterology, Indianapolis, USA, 5Guy’s and St Thomas’ NHS Foundation Trust, Gastroenterology, London, UK

P127 Lemann Index for Assessment of Crohn’s disease association with the quality of life, endoscopic disease activity and magnetic resonance indices of activity

ECCO'20 Vienna

Year: 2020
Authors:

V. Straksyte1, G. Kiudelis2, L. Kupcinskas2, I. Zaboriene1

1Lithuanian University of Health Science, Radiology department, Kaunas, Lithuania, 2Lithuanian University of Health Science, Gastroenterology department, Kaunas, Lithuania

P128 Colorectal cancer surveillance with chromoendoscopy in inflammatory bowel disease: results from a real life experience

ECCO'20 Vienna

Year: 2020
Authors:

C. Rubín De Célix Vargas, M. Chaparro, J.A. Moreno, C. Santander, J.P. Gisbert

Gastroenterology Unit, Hospital Universitario de La Princesa. Instituto de Investigación Sanitaria Princesa IIS-IP, Universidad Autónoma de Madrid. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Gastroenterology Unit, Madrid, Spain

P129 Value of diffusion-weighted magnetic resonance enterocolonography for assessing Crohn’s disease activity

ECCO'20 Vienna

Year: 2020
Authors:

V. Straksyte1, G. Kiudelis2, L. Kupcinskas2, I. Zaboriene1

1LIthuanian University of Health Science, Radiology department, Kaunas, Lithuania, 2LIthuanian University of Health science, Gastroenterology department, Kaunas, Lithuania

P130 Faecal calprotectin is a reliable tool to assess endoscopic activity in ulcerative colitis except for short-extent proctitis

ECCO'20 Vienna

Year: 2020
Authors:

R. Collin, R. Minet-Quinard, L. Blayac, L. Manlay, B. Pereira, A. Buisson

CHU Estaing, Department of Digestive and Hepatobiliary Medicine, Department of Gastroenterology, Clermont-Ferrand, France

P131 The simplified MARIA score is strongly correlated with the MARIA and Clermont scores to analyse the luminal activity of Crohn’s disease (CD) in magnetic resonance and is easier to calculate

ECCO'20 Vienna

Year: 2020
Authors:

X. Roblin1, S. Jardin2, M. cuilleron2, P. veyrard1, G. boschetti3, A.E. berger4, B. flourie3, S. nancey3, S. paul4

1CHU Saint Etienne – Hospital Nord, Department of Gastroenterology and Hepatology, Inserm, CIC1408, Saint Priest en Jarez, France, 2CHU Saint Etienne – Hospital Nord, Radiology, Saint Priest en Jarez, France, 3CHU Lyon Sud, Department of Gastroenterology and Hepatology, Lyon, France, 4CHU Saint Etienne, Hospital Nord, Immunology, Saint Priest en Jarez, France

P132 Performance of a severity score in risk stratification of patients with ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

B. Morão, C. Frias Gomes, C. Gouveia, M.P. Costa Santos, J. Torres

Hospital Beatriz Ângelo, Surgery Department, Gastroenterology Division, Lisbon, Portugal

P133 Pregnancy in inflammatory bowel disease: experience of a Chilean cohort

ECCO'20 Vienna

Year: 2020
Authors:

P. Núñez1, E. Sepúlveda2, D. Simian3, C. Figueroa3, L. Flores3, P. Ibáñez3, U. Kronberg4, J. Lubascher3, G. Pizarro3, R. Quera3

1San Juan de Dios Hospital, Gastroenterology Department – IBD Fellow Clínica Las Condes, Santiago, Chile, 2Clínica Las Condes, Gynecology and Obstetrics Department, Santiago, Chile, 3Clínica Las Condes, Gastroenterology Department – Inflammatory Bowel Disease Program, Santiago, Chile, 4Clínica Las Condes, Surgery Department, Colorectal Unit – Inflammatory Bowel Disease Program, Santiago, Chile

P134 Patient empowerment in inflammatory bowel disease (IBD): early education at a new diagnosis IBD clinic (NDC)

ECCO'20 Vienna

Year: 2020
Authors:

V.A. Fenech1, N. Kamperidis1, T. Tyrrell1, L. Dyall1, R. Fofaria1, R. Misra1, S. Barber2, S. Randall3, J. Shah4, N. Arebi1

1St Mark’s Hospital, Department of Gastroenterology, London, UK, 2National Institute for Health Research, Applied Research Collaborations, Northwest London, UK, 3Patient Information Forum, Head of Strategy and Partnership, London, UK, 4Crohns and Colitis UK, Publications and Information Manager, London, UK

P135 Disease-related worries and concerns in UK patients with ulcerative colitis: 2-year data from ICONIC

ECCO'20 Vienna

Year: 2020
Authors:

N. Bhala1, A. Hart2, D. Watts3, S. Lewis4, S. Ghosh5, S. van Haaren6, C. Hansell6, T. Ahmad7

1Queen Elizabeth Hospital Birmingham, Gastroenterology, Birmingham, UK, 2St Mark’s Hospital, IBD Unit, Harrow, UK, 3NHS Forth Valley, Gastroenterology, Stirling, UK, 4Plymouth Hospitals NHS Trust, Gastroenterology, Plymouth, UK, 5University Hospitals Birmingham NHS Foundation Trust, Gastroenterology, Birmingham, UK, 6AbbVie Ltd., Medical, Maidenhead, UK, 7Royal Devon and Exeter Hospital, Gastroenterology, Exeter, UK

P136 Faecal calprotectin as therapeutic target in patients with Crohn’s disease treated with anti-TNF: a meta-analysis of individual data

ECCO'20 Vienna

Year: 2020
Authors:

A. Mami1, S. Nancey2, D. Pugliese3, P. Molander4, G. Boschetti2, I. Nogueira5, B. Pereira6, A. Buisson1

1CHU Estaing, Department of Digestive and Hepatobiliary Medicine- Department of Gastroenterology, Clermont-Ferrand, France, 2CHU Lyon-Sud, Gastroenterology, Lyon, France, 3Fondazione Policlinico A. Gemelli IRCCS- Rome- Italy, IBD Unit Presidio Columbus, Rome, Italy, 4Helsinki University Hospital- Meilahti Hospital, Hus, Helsinski, Finland, 5Federal University of São Paulo–UNIFESP-, Gastroenterology, Sao Paulo, Brazil, 6CHU, Biostatistics unit, Clermont-Ferrand, France